DİKMEN, M. And Engür, S. 2015. Affymetrix Primeview Array Analysis of Neurokinin 1 Receptor Antagonist Aprepitant on Glioblastoma Cells. 1st Pharmacogenomıcs İstanbul Summit, Increasing The Safety And Effectiveness of Personalized Therapy for Metabolic Disorders , (İstanbul, Turkey), 90.

DİKMEN, M., & Engür, S., (2015). Affymetrix Primeview Array Analysis of Neurokinin 1 Receptor Antagonist Aprepitant on Glioblastoma Cells . 1st Pharmacogenomıcs İstanbul Summit, Increasing The Safety And Effectiveness of Personalized Therapy for Metabolic Disorders (pp.90). İstanbul, Turkey

DİKMEN, MİRİŞ, And Selin Engür. "Affymetrix Primeview Array Analysis of Neurokinin 1 Receptor Antagonist Aprepitant on Glioblastoma Cells," 1st Pharmacogenomıcs İstanbul Summit, Increasing The Safety And Effectiveness of Personalized Therapy for Metabolic Disorders, İstanbul, Turkey, 2015

DİKMEN, MİRİŞ And Engür, Selin. "Affymetrix Primeview Array Analysis of Neurokinin 1 Receptor Antagonist Aprepitant on Glioblastoma Cells." 1st Pharmacogenomıcs İstanbul Summit, Increasing The Safety And Effectiveness of Personalized Therapy for Metabolic Disorders , İstanbul, Turkey, pp.90, 2015

DİKMEN, M. And Engür, S. (2015) . "Affymetrix Primeview Array Analysis of Neurokinin 1 Receptor Antagonist Aprepitant on Glioblastoma Cells." 1st Pharmacogenomıcs İstanbul Summit, Increasing The Safety And Effectiveness of Personalized Therapy for Metabolic Disorders , İstanbul, Turkey, p.90.

@conferencepaper{conferencepaper, author={MİRİŞ DİKMEN And author={Selin Engür}, title={Affymetrix Primeview Array Analysis of Neurokinin 1 Receptor Antagonist Aprepitant on Glioblastoma Cells}, congress name={1st Pharmacogenomıcs İstanbul Summit, Increasing The Safety And Effectiveness of Personalized Therapy for Metabolic Disorders}, city={İstanbul}, country={Turkey}, year={2015}, pages={90} }